<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F1052038-9134-4F98-874C-90A7A24A17E2"><gtr:id>F1052038-9134-4F98-874C-90A7A24A17E2</gtr:id><gtr:name>European Scientific Working group on Influenza (ESWI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DBCEE86-6873-4669-9B35-B4EEEAE13F52"><gtr:id>3DBCEE86-6873-4669-9B35-B4EEEAE13F52</gtr:id><gtr:name>Royal Liverpool University NHS Hospitals</gtr:name><gtr:address><gtr:line1>Prescot Street</gtr:line1><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L7 8XP</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/28E64D17-4819-42F5-80D0-C46290BF09CF"><gtr:id>28E64D17-4819-42F5-80D0-C46290BF09CF</gtr:id><gtr:name>The Global Health Network</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9F7C81EF-E4F5-45C5-A902-F4CAB61D4A82"><gtr:id>9F7C81EF-E4F5-45C5-A902-F4CAB61D4A82</gtr:id><gtr:name>NHS Greater Glasgow and Clyde (NHSGGC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F1052038-9134-4F98-874C-90A7A24A17E2"><gtr:id>F1052038-9134-4F98-874C-90A7A24A17E2</gtr:id><gtr:name>European Scientific Working group on Influenza (ESWI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DBCEE86-6873-4669-9B35-B4EEEAE13F52"><gtr:id>3DBCEE86-6873-4669-9B35-B4EEEAE13F52</gtr:id><gtr:name>Royal Liverpool University NHS Hospitals</gtr:name><gtr:address><gtr:line1>Prescot Street</gtr:line1><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L7 8XP</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/28E64D17-4819-42F5-80D0-C46290BF09CF"><gtr:id>28E64D17-4819-42F5-80D0-C46290BF09CF</gtr:id><gtr:name>The Global Health Network</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9F7C81EF-E4F5-45C5-A902-F4CAB61D4A82"><gtr:id>9F7C81EF-E4F5-45C5-A902-F4CAB61D4A82</gtr:id><gtr:name>NHS Greater Glasgow and Clyde (NHSGGC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/317F1E6E-B604-499D-9FA5-7F0883CED9E9"><gtr:id>317F1E6E-B604-499D-9FA5-7F0883CED9E9</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Openshaw</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_G1001212"><gtr:id>DC5AFC2A-8D33-4EC7-A039-3CCC3431F05B</gtr:id><gtr:title>MOSAIC - cohort of hospitalised H1N1 patients</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_G1001212</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>We have assembled a team of 42 investigators from England and Scotland, bringing their combined expertise to the intensive study of a group of hospitalised patients with influenza. The integration and coordination of all the studies is a logistic challenge, and case ascertainment, definition and sample collection underpins the collaborative network. On this base, some of the UKs best clinical and basic research groups will conduct an integrated|study of influenza virology, host RNA transcriptome and of cellular and humoral immune responses to influenza viral infection. The same patients will also be tested for levels of soluble mediators (cytokines and chemokines) in various body fluids, so allowing the crosscorrelation of the clinical features, virology and RNA transcription profiles on a population|basis. All of this will be linked to the study of the host genome and the bacterial and viral|microbiota present in the respiratory tract as disease evolves, using 16s RNA methods to characterise bacterial populations without the need for culture. The collaborative study of a single set of hospitalised individuals will lead to a wealth of information and the cross correlations between different research outputs will provide|unprecedented opportunities for understanding the pathogenesis of influenza.Research Framework, the Health Protection Agency, London School of Hygiene and Tropical Medicine and the Sanger Institute.|</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1763664</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>We commissioned the famous illustrator Steven Appleby and animator Pete Bishop to create a video 'How to Catch Flu' and an interactive stand exemplifying MOSAIC's research. A novel flu dominoes game was created with a range of 100 hand-drawn characters, including the 'at-risk' groups (elderly, obsess, pregnant, asthmatic etc.); some dominoes were 'vaccinated' (unable to topple). A table-top city scape was designed which allowed members of the public to create outbreaks. Participants were also invited to sketch their own virus. https://www.flickr.com/photos/123813534@N03/sets/

'How to Catch Flu' was developed with a wide age range in mind. It conveys clear but subtle messages about how to prevent flu and what to do if you catch it. It has been shown to focus groups of children, to planners from Health Protection England, to groups of paediatricians and others and has been acclaimed as a highly engaging and memorable output from the grant. https://www.youtube.com/watch?v=nTtCBzOV0BY http://www.mediafire.com/download/39pocth3p6i0jcv/Happy720p.mp4.zip
See also: http://www1.imperial.ac.uk/mosaic/ https://twitter.com/MOSAICStudy</gtr:description><gtr:id>06445AD6-966E-473E-AECD-2427BF71D2EB</gtr:id><gtr:impact>Video has since been uploaded onto National STEM database as a resource for teachers</gtr:impact><gtr:outcomeId>545cf57ac90fe7.69488438</gtr:outcomeId><gtr:title>How to Catch Flu</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>http://www1.imperial.ac.uk/mosaic/howtocatchflu/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MOSAIC (Mechanisms of Severe Acute Influenza Consortium</gtr:description><gtr:id>C71DBD7F-90C2-4881-A51D-B5089779AF48</gtr:id><gtr:impact>The Consortium has generated a diverse range of clinical and laboratory datasets (as described above) and we are now entering the analytical phase where clinical data is being aligned with the laboratory output and ultimately the entire dataset will be brought together in a cross-cutting analysis.</gtr:impact><gtr:outcomeId>dXNtPTx8S4n-1</gtr:outcomeId><gtr:partnerContribution>MOSAIC was set up to comprehensively investigate the pathogenesis of pH1N1/09 swine flu. With this objective in mind samples from patients recrutied to the project were sent to our partners in UK research centres in England and Scotland, who between them have produced data on host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses). The aim of this collaborative, multi-discipline approach is to establish those factors that contribute to variations in disease severity. In addition several of our collaborators have provided clinical, methodological and analytical input.</gtr:partnerContribution><gtr:piContribution>Primary site for patient recruitment. 
Consortium management and research leadership.
Anaylsis of cytokine/ chemokine profiles and transcriptomic signatures of patients recrutied to the study using a variety of sample types at the Centre for Respiratory Infections.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Scientific Working group on Influenza (ESWI)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>ESWI</gtr:description><gtr:id>71873FE1-F58E-4ED7-A76E-5CD13D1DA57E</gtr:id><gtr:impact>Openshaw acted as vice president</gtr:impact><gtr:outcomeId>545ca5c8f0cd56.75374108-1</gtr:outcomeId><gtr:partnerContribution>ESWI ()European Scientific Working Group on Influenza) was established in 1993. Along with the main stakeholders ESWI aims to educe the burden of influenza in Europe. The Members are twelve scientific experts, health care professionals, public health officials, at-risk patients and the elderly. ESWI collaborates with the World Health Organisation to enhance vaccine coverage of people at high risk of getting severe complications when infected with influenza.</gtr:partnerContribution><gtr:piContribution>Openshaw served as ESWI's vice-president for 5 years, stepping down in September 2014.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Emergency Preparedness and Response Unit</gtr:department><gtr:description>PREPARE</gtr:description><gtr:id>0E8F2433-B0EA-4340-BA9E-A575BFC1A4BF</gtr:id><gtr:impact>Openshaw is a co-applicant and receives funding to do work that builds on the findings of MOSAIC</gtr:impact><gtr:outcomeId>545ca751e2dcb2.09577383-1</gtr:outcomeId><gtr:partnerContribution>PREPARE (Platform foR European Preparedness Against (RE-) emegering Epidemics) was funded by the EU commission in 2013. It is a consortium of 21 organisations that aims to identify and implement solutions to roadblocks against rapid implementation of clinical research during severe outbreakshttp://www.prepare-europe.eu</gtr:partnerContribution><gtr:piContribution>Openshaw is active in several of the work packages</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MOSAIC (Mechanisms of Severe Acute Influenza Consortium</gtr:description><gtr:id>5E5E689D-3B28-4431-916E-35B7DA6F6191</gtr:id><gtr:impact>The Consortium has generated a diverse range of clinical and laboratory datasets (as described above) and we are now entering the analytical phase where clinical data is being aligned with the laboratory output and ultimately the entire dataset will be brought together in a cross-cutting analysis.</gtr:impact><gtr:outcomeId>dXNtPTx8S4n-6</gtr:outcomeId><gtr:partnerContribution>MOSAIC was set up to comprehensively investigate the pathogenesis of pH1N1/09 swine flu. With this objective in mind samples from patients recrutied to the project were sent to our partners in UK research centres in England and Scotland, who between them have produced data on host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses). The aim of this collaborative, multi-discipline approach is to establish those factors that contribute to variations in disease severity. In addition several of our collaborators have provided clinical, methodological and analytical input.</gtr:partnerContribution><gtr:piContribution>Primary site for patient recruitment. 
Consortium management and research leadership.
Anaylsis of cytokine/ chemokine profiles and transcriptomic signatures of patients recrutied to the study using a variety of sample types at the Centre for Respiratory Infections.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Emergency Preparedness and Response Unit</gtr:department><gtr:description>PREPARE</gtr:description><gtr:id>8D58FCD3-D3EF-40FA-8E30-FE79EB919358</gtr:id><gtr:impact>Openshaw is a co-applicant and receives funding to do work that builds on the findings of MOSAIC</gtr:impact><gtr:outcomeId>58c2c6214c5684.35590982-1</gtr:outcomeId><gtr:partnerContribution>PREPARE (Platform foR European Preparedness Against (RE-) emerging Epidemics) was funded by the EU commission in 2013. It is a consortium of 21 organisations that aims to identify and implement solutions to roadblocks against rapid implementation of clinical research during severe outbreaks http://www.prepare-europe.eu</gtr:partnerContribution><gtr:piContribution>Openshaw is active in several of the work packages</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Community Health Sciences Nottingham</gtr:department><gtr:description>MOSAIC (Mechanisms of Severe Acute Influenza Consortium</gtr:description><gtr:id>BC47ADED-4779-4152-BA8C-C613011087C9</gtr:id><gtr:impact>The Consortium has generated a diverse range of clinical and laboratory datasets (as described above) and we are now entering the analytical phase where clinical data is being aligned with the laboratory output and ultimately the entire dataset will be brought together in a cross-cutting analysis.</gtr:impact><gtr:outcomeId>dXNtPTx8S4n-9</gtr:outcomeId><gtr:partnerContribution>MOSAIC was set up to comprehensively investigate the pathogenesis of pH1N1/09 swine flu. With this objective in mind samples from patients recrutied to the project were sent to our partners in UK research centres in England and Scotland, who between them have produced data on host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses). The aim of this collaborative, multi-discipline approach is to establish those factors that contribute to variations in disease severity. In addition several of our collaborators have provided clinical, methodological and analytical input.</gtr:partnerContribution><gtr:piContribution>Primary site for patient recruitment. 
Consortium management and research leadership.
Anaylsis of cytokine/ chemokine profiles and transcriptomic signatures of patients recrutied to the study using a variety of sample types at the Centre for Respiratory Infections.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Global Health Network</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>International Severe Acute Respiratory Infection Consortium (ISARIC)</gtr:department><gtr:description>ISARIC</gtr:description><gtr:id>5C9BB444-984D-4CC9-8FBA-9518DADEB5C9</gtr:id><gtr:impact>MOSAIC assisted in initial set up of of ISARIC and MOSAIC members are active in Council</gtr:impact><gtr:outcomeId>545ca24a8a6483.04674043-1</gtr:outcomeId><gtr:partnerContribution>ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) is a global initiative aiming to ensure that clinical researchers have the open access protocols and data-sharing processes needed to facilitate a rapid response to emerging diseases that may turn into epidemics or pandemics https://isaric.tghn.org</gtr:partnerContribution><gtr:piContribution>MOSAIC contributed to the initial set up of the project with core document development and refinement, as well as suggesting ways to measure nCoV cytokines. Openshaw, Dunning and Semple are ISARIC Council members</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Greater Glasgow and Clyde (NHSGGC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gartnaval West of Scotland Specialist Virology Centre</gtr:department><gtr:description>MOSAIC (Mechanisms of Severe Acute Influenza Consortium</gtr:description><gtr:id>65EC2384-B3C7-4133-9AF5-E0962AA87ACC</gtr:id><gtr:impact>The Consortium has generated a diverse range of clinical and laboratory datasets (as described above) and we are now entering the analytical phase where clinical data is being aligned with the laboratory output and ultimately the entire dataset will be brought together in a cross-cutting analysis.</gtr:impact><gtr:outcomeId>dXNtPTx8S4n-4</gtr:outcomeId><gtr:partnerContribution>MOSAIC was set up to comprehensively investigate the pathogenesis of pH1N1/09 swine flu. With this objective in mind samples from patients recrutied to the project were sent to our partners in UK research centres in England and Scotland, who between them have produced data on host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses). The aim of this collaborative, multi-discipline approach is to establish those factors that contribute to variations in disease severity. In addition several of our collaborators have provided clinical, methodological and analytical input.</gtr:partnerContribution><gtr:piContribution>Primary site for patient recruitment. 
Consortium management and research leadership.
Anaylsis of cytokine/ chemokine profiles and transcriptomic signatures of patients recrutied to the study using a variety of sample types at the Centre for Respiratory Infections.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Liverpool University Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MOSAIC (Mechanisms of Severe Acute Influenza Consortium</gtr:description><gtr:id>7F7D1108-62B2-476B-BF41-A10BDEE1077F</gtr:id><gtr:impact>The Consortium has generated a diverse range of clinical and laboratory datasets (as described above) and we are now entering the analytical phase where clinical data is being aligned with the laboratory output and ultimately the entire dataset will be brought together in a cross-cutting analysis.</gtr:impact><gtr:outcomeId>dXNtPTx8S4n-8</gtr:outcomeId><gtr:partnerContribution>MOSAIC was set up to comprehensively investigate the pathogenesis of pH1N1/09 swine flu. With this objective in mind samples from patients recrutied to the project were sent to our partners in UK research centres in England and Scotland, who between them have produced data on host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses). The aim of this collaborative, multi-discipline approach is to establish those factors that contribute to variations in disease severity. In addition several of our collaborators have provided clinical, methodological and analytical input.</gtr:partnerContribution><gtr:piContribution>Primary site for patient recruitment. 
Consortium management and research leadership.
Anaylsis of cytokine/ chemokine profiles and transcriptomic signatures of patients recrutied to the study using a variety of sample types at the Centre for Respiratory Infections.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MOSAIC (Mechanisms of Severe Acute Influenza Consortium</gtr:description><gtr:id>79B1E512-DA23-4522-B4FE-93CBA173FE6D</gtr:id><gtr:impact>The Consortium has generated a diverse range of clinical and laboratory datasets (as described above) and we are now entering the analytical phase where clinical data is being aligned with the laboratory output and ultimately the entire dataset will be brought together in a cross-cutting analysis.</gtr:impact><gtr:outcomeId>dXNtPTx8S4n-7</gtr:outcomeId><gtr:partnerContribution>MOSAIC was set up to comprehensively investigate the pathogenesis of pH1N1/09 swine flu. With this objective in mind samples from patients recrutied to the project were sent to our partners in UK research centres in England and Scotland, who between them have produced data on host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses). The aim of this collaborative, multi-discipline approach is to establish those factors that contribute to variations in disease severity. In addition several of our collaborators have provided clinical, methodological and analytical input.</gtr:partnerContribution><gtr:piContribution>Primary site for patient recruitment. 
Consortium management and research leadership.
Anaylsis of cytokine/ chemokine profiles and transcriptomic signatures of patients recrutied to the study using a variety of sample types at the Centre for Respiratory Infections.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HPRU</gtr:description><gtr:id>4FA0DD76-62FD-4202-B7B3-E7BCD75C3081</gtr:id><gtr:impact>Continuing research already undertaken by MOSAIC</gtr:impact><gtr:outcomeId>58c2c4c5a13c55.31884866-1</gtr:outcomeId><gtr:partnerContribution>Building on research done by MOSAIC</gtr:partnerContribution><gtr:piContribution>Health Protection Research Unit on Respiratory Viruses, Openshaw is lead on 'RSV theme' and a member of the management committee.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>MOSAIC (Mechanisms of Severe Acute Influenza Consortium</gtr:description><gtr:id>DAADED24-ED02-4C3F-A8AA-B3CA71EBF3EF</gtr:id><gtr:impact>The Consortium has generated a diverse range of clinical and laboratory datasets (as described above) and we are now entering the analytical phase where clinical data is being aligned with the laboratory output and ultimately the entire dataset will be brought together in a cross-cutting analysis.</gtr:impact><gtr:outcomeId>dXNtPTx8S4n-5</gtr:outcomeId><gtr:partnerContribution>MOSAIC was set up to comprehensively investigate the pathogenesis of pH1N1/09 swine flu. With this objective in mind samples from patients recrutied to the project were sent to our partners in UK research centres in England and Scotland, who between them have produced data on host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses). The aim of this collaborative, multi-discipline approach is to establish those factors that contribute to variations in disease severity. In addition several of our collaborators have provided clinical, methodological and analytical input.</gtr:partnerContribution><gtr:piContribution>Primary site for patient recruitment. 
Consortium management and research leadership.
Anaylsis of cytokine/ chemokine profiles and transcriptomic signatures of patients recrutied to the study using a variety of sample types at the Centre for Respiratory Infections.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HPRU</gtr:description><gtr:id>EA8F4038-A45B-4B12-B9C7-CB518BB64E0D</gtr:id><gtr:impact>Continuing research already undertaken by MOSAIC</gtr:impact><gtr:outcomeId>545ca7e674b855.32086148-1</gtr:outcomeId><gtr:partnerContribution>Building on research done by MOSAIC</gtr:partnerContribution><gtr:piContribution>Health Protection Research Unit on Respiratory Viruses, Openshaw is lead on 'RSV theme' and a member of the management committee.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>MOSAIC (Mechanisms of Severe Acute Influenza Consortium</gtr:description><gtr:id>B30290E6-986A-4AD9-AA22-D8822BFCE5C1</gtr:id><gtr:impact>The Consortium has generated a diverse range of clinical and laboratory datasets (as described above) and we are now entering the analytical phase where clinical data is being aligned with the laboratory output and ultimately the entire dataset will be brought together in a cross-cutting analysis.</gtr:impact><gtr:outcomeId>dXNtPTx8S4n-3</gtr:outcomeId><gtr:partnerContribution>MOSAIC was set up to comprehensively investigate the pathogenesis of pH1N1/09 swine flu. With this objective in mind samples from patients recrutied to the project were sent to our partners in UK research centres in England and Scotland, who between them have produced data on host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses). The aim of this collaborative, multi-discipline approach is to establish those factors that contribute to variations in disease severity. In addition several of our collaborators have provided clinical, methodological and analytical input.</gtr:partnerContribution><gtr:piContribution>Primary site for patient recruitment. 
Consortium management and research leadership.
Anaylsis of cytokine/ chemokine profiles and transcriptomic signatures of patients recrutied to the study using a variety of sample types at the Centre for Respiratory Infections.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release (Sanger Isntitute)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83510801-D225-4DF9-9DEB-58F55064CC57</gtr:id><gtr:impact>News release outlined major findings from a consortium publication. The work described identified a human gene (IFITM3) that influences how we respond to influenza infection. People who carry a particular variant are significantly more likely to be hospitalised when they fall ill with influenza than those who carry other variants

Significant media interest followed this release including and interview on BBC radio 4's today programme</gtr:impact><gtr:outcomeId>tkhxHyxqHFf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Openshaw talks</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1F83FD12-4D5F-4642-B823-CB7DD53A774A</gtr:id><gtr:impact>Openshaw Chaired sessions and gave keynote speeches during conference

N/A</gtr:impact><gtr:outcomeId>545cc0515fbc37.93226892</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Croonian lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BCCE2362-BB06-4CC6-9BDE-06C182C28F1C</gtr:id><gtr:impact>Croonian Lecture

RCP Croonian lecture in 2013</gtr:impact><gtr:outcomeId>J6a1ngLDbsY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Openshaw lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>32ECDF18-03A9-4C4C-A02B-4961CE4CD5FE</gtr:id><gtr:impact>Stimulate conversation as part of RSV talks

N/A</gtr:impact><gtr:outcomeId>545cbdb3e881c7.10561549</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Live Presentation in Brussels</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A474ACE1-B2F1-41AD-BA2A-FC711F13DA56</gtr:id><gtr:impact>Last year I gave a 30 minute stage performance in a theatre in Brussels (the Albert Hall) to a public audience, recounting anecdotes and describing my sources of scientific inspiration.

N/A</gtr:impact><gtr:outcomeId>XN9bSiU7et2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Openshaw plenary lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D1816EB9-4069-4A21-A9CB-C12F3202EF44</gtr:id><gtr:impact>EFIS Lecture Award: &amp;quot;Protective and inflammatory responses in respiratory virus infections.&amp;quot;

N/A</gtr:impact><gtr:outcomeId>545cc009e35076.75006678</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.irishimmunology.ie/ISI%20Programme%202014.pdf</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How to Catch Flu film</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>123CAE21-D916-4606-8EFB-CA6AE0902B27</gtr:id><gtr:impact>We commissioned the famous illustrator Steven Appleby and animator Pete Bishop to create a video 'How to Catch Flu' and an interactive stand exemplifying MOSAIC's research. A novel flu dominoes game was created with a range of 100 hand-drawn cahracters, including 'at risk' groups (elderly, obese, pregnant, asthmatic, etc); some dominoes were 'vaccinated' (unable to topple). A table-top cityscape was designed which allowed members of the public to vreate outbreaks. Participants were also invited to sketch their own virus. http://www.flickr.com/photos/123813534@N03/sets

'How to Catch Flu' was developed with a wide range in mind. It conveys clear but subtle messages about how to rpevent flu and what to do if you catch it. It has been shown to focus groups of children, to planners from Health Protection England, to groups of paediatricians and others and has been acclaimed as a highly engaging and memorable output.

It has been added to the National STEM Centre database for teaching tools</gtr:impact><gtr:outcomeId>545cb086c39124.05397627</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www1.imperial.ac.uk/mosaic/howtocatchflu/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Understanding and treating the flu virus AHSC Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FC3A2F04-3F04-47C5-8EA9-731455054516</gtr:id><gtr:impact>Peter Openshaw will discuss the MOSAIC project which collected data from over 250 flu patients to inform new treatments</gtr:impact><gtr:outcomeId>58c6803fea48e5.40389317</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imperial Festival of Science</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E2DC5B87-8D93-4F5B-9198-DAE55446CD62</gtr:id><gtr:impact>Festival attended by over 10,000 people and the MOSAIC stall was one of the most popular with visitors. Openshaw also gave a talk 'Spanish Flu to Swine Flu' which was open to the public

N/A</gtr:impact><gtr:outcomeId>545cacda0175f5.90620902</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/eventssummary/event_30-4-2014-10-44-37</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Inspired Tales</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>75924220-8EE1-4F91-B968-8881883A00A9</gtr:id><gtr:impact>Video edited and put online

Asked if I would do another on a different topic</gtr:impact><gtr:outcomeId>mevJotV56pM</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Masterclass</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F786C117-FBA5-4E43-B5CF-5248121E6685</gtr:id><gtr:impact>We hosted a publically accessible immunology 'Masterclass' last year at the Wellcome Trust at which Jonathan Yewdell inspired an audience that included many students from London schools.

N/A</gtr:impact><gtr:outcomeId>fo1BBuLH6ht</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview (Today Programme, BBC R4)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FE593932-85D5-4269-8870-88A4EFBB92F5</gtr:id><gtr:impact>Following a press release from the Sanger institute that outlined the findings from a consortium publication on a genetic correlate of influenza severity, the Today programme ran a report on the subject which featured interviews with the head of the consortium and the PI from the Sanger. The report also showcased the scope and originality of the MOSAIC consortium and it's potential impact on the study and treatment of future pandemics.

This activity raised the profile of MOSAIC and it's output to a non-scientific audience.</gtr:impact><gtr:outcomeId>J7F9hovmxok</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press conference, Wellcome Trust</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>990F33C4-4806-4A90-8D17-334598EDFC09</gtr:id><gtr:impact>Excellent turnout of specialist science journalists and those looking for a flu story. About 30 attenees

Several national newspapers published stories mentioning ongoing studies, contributing to the awareness for the need for seasonal flu vaccines</gtr:impact><gtr:outcomeId>Pjkhov8ZhC7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Openshaw talk (open to public)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>184805BF-18C3-412E-97FF-EB7C9A924CB7</gtr:id><gtr:impact>Talk on influenza outbreaks, open to members of the public

Raise public awareness</gtr:impact><gtr:outcomeId>545cbe8bda0129.22665107</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.friendsofimperial.org.uk/FOIC-Index.php?pg=FullEvent&amp;from=Past-Events&amp;yr=13&amp;ev=130</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>73803260-5929-4FA8-A0AF-AFFCAC58F21C</gtr:id><gtr:impact>Openshaw also delivered a talk on 'Flu A Pandemic In Waiting?' at the Festival

N/A</gtr:impact><gtr:outcomeId>545cade2b065b1.46778535</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www1.imperial.ac.uk/mosaic/events/cheltenham2014/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A02BACE3-F966-4A1E-B35E-92393694C44A</gtr:id><gtr:impact>TV appearance on &amp;quot;Daybreak&amp;quot;

Asked to speak on flu vaccines</gtr:impact><gtr:outcomeId>YnghVzXp95g</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Newsnight feature</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B596DA8A-92EB-4FED-ACB9-AA2B554ED533</gtr:id><gtr:impact>Part of a BBC Newsnight feature on pH1N1 influenza, the impact it was having during the winter of 2010/11 and research efforts to understand pathogenesis.

N/A</gtr:impact><gtr:outcomeId>VS9TMijrvgj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Society for General Microbiology</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7C5389EA-2982-4292-B3C8-3CAB54330AED</gtr:id><gtr:impact>Public outreach for MOSAIC study

N/A</gtr:impact><gtr:outcomeId>545cad4132d7c9.34991060</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www1.imperial.ac.uk/mosaic/events/sgm2014/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical marvels: how vaccines protect, and what can go wrong</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9293CF51-E745-4ABE-9E7D-50A86F52597F</gtr:id><gtr:impact>120 staff, pupils and parents attened this talk, which aimed to entertain and inform about the science, policy and pitfalls behind vaccines.

Several enquiries about internships and university applications.</gtr:impact><gtr:outcomeId>pvqypCQT8Ai</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Openshaw talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>01496712-24EA-449E-8BF9-F4C9053EA037</gtr:id><gtr:impact>Openshaw Chaired sessions at conference as well as giving talks on RSV

N/A</gtr:impact><gtr:outcomeId>545cbee34146b2.73839583</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Panel discussion</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1AABB193-E2BA-4DE3-811D-7F6B875C33D1</gtr:id><gtr:impact>International Influenza Networks Meeting (Arizona)

We would like you to participate in the Panel on &amp;quot;Clinical/Research Networks&amp;quot; on Monday, January 14, 2013. During the panel discussion, you would present on the Mechanisms of Severe Acute Influenza Consortium (MOSAIC) - their goals, unique attributes, information gathered, and current strengths/gaps. A preliminary meeting agenda is attached for your review.</gtr:impact><gtr:outcomeId>SbYbiAfZxqu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Natural History Museum Science Event</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3686EE1E-F7FD-4D79-BF51-FFFA2B22ACCA</gtr:id><gtr:impact>MOSAIC stand at Natural History Museum Science Uncovered event

N/A</gtr:impact><gtr:outcomeId>545caeb6d0fec0.77816539</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www1.imperial.ac.uk/mosaic/events/scienceuncovered/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Openshaw talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A035100B-EF6B-4AD8-8E0B-06D2A5D8D70C</gtr:id><gtr:impact>The BSI Summer School is a unique learning experience aimed primarily at individuals who are new to the field of immunology or who want to enhance their immunological knowledge. To be held within the historic city of Edinburgh, the 2014 BSI summer school will feature presentations from leading immunologists who will teach the fundamental principles of immunology in the context of cutting edge research.
? Immunology taught by world-leading Immunologists
? Fundamental and current topics in Immunology
? Interactive tutorials and workshops
? Immunology 'Dragon's Den'
? Fantastic Social activities.


N/A</gtr:impact><gtr:outcomeId>545cbf7bcb8da6.80888495</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://immunology.org/events--meetings/summer-schoo-2014/--bsi-events--meeting-edinburgh-summer-school-2014-home-page</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cafe' Scientifique</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>00E574D0-4295-42EF-A67B-617BAFC725DE</gtr:id><gtr:impact>The presentation was given in relation to the H1N1 Influenza Pandemic

Students were interested in the discussion</gtr:impact><gtr:outcomeId>CAQGsx52fps</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk about research on MOSAIC to the Imperial College Academic Health Science Centre</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D1ADF8E5-418D-42E4-85AC-8E453188D6A0</gtr:id><gtr:impact>To speak at the AHSC seminar series about the research into influenza and the MOSAIC project.</gtr:impact><gtr:outcomeId>58c2d068c8c476.10939090</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Openshaw talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BC5491D8-C045-4EA2-AA6B-0BBFE98C95E1</gtr:id><gtr:impact>Openshaw gave keynote lecture

N/A</gtr:impact><gtr:outcomeId>545cc09fecbe40.24293698</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>568695</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Research Centre (BRC)</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>46FD1F70-7C4C-40E3-A8A7-6C75A4E87497</gtr:id><gtr:outcomeId>545ce4d8987ac8.55345242</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Senior Investigator</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>A39BAD3C-C82F-4807-AA6B-B4C718DAC6AD</gtr:id><gtr:outcomeId>545ce52fe865f6.36316751</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>Belgium, Kingdom of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>PREPARE</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>University of Antwerp</gtr:fundingOrg><gtr:fundingRef>60525</gtr:fundingRef><gtr:id>C827BDF4-B7A6-421D-8600-0198FC3E2A1F</gtr:id><gtr:outcomeId>545ce3eb5e9d23.27841200</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3427262</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Respiratory Infection Health Protection Unit (HPRU)</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>46AE9831-773A-4D82-A544-24E42600A949</gtr:id><gtr:outcomeId>56defc7fa980b8.14459576</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC EMINENT grant</gtr:description><gtr:end>2021-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C11D64D6-0575-4AE0-A6FD-10EABDC5DE91</gtr:id><gtr:outcomeId>56defb5b5316d8.55010359</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Research</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Imperial College Healthcare NHS Trust</gtr:fundingOrg><gtr:id>33676AB6-773A-4504-A93A-B3F5FEE58B8C</gtr:id><gtr:outcomeId>545ce746ee3102.22337884</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1352200</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP7</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>602525</gtr:fundingRef><gtr:id>3CC3D84B-BAD4-4813-9F5F-D0D68A7259DC</gtr:id><gtr:outcomeId>ijRNkYJaXGB</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2550000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Translational Fund</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>CACF2D15-A4CC-4FA4-AC4C-9D6C0907C3A5</gtr:id><gtr:outcomeId>56dee44d5d5691.31442480</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PREPARE</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>9176AF49-73BD-4947-B85A-88EFC2D545AB</gtr:id><gtr:outcomeId>545cb1b456f5b7.78630510</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European Scientific Working Group on Influenza (ESWI)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>7F0DA364-90E0-4DC7-9B64-E9E7319EE5C9</gtr:id><gtr:impact>I am Vice-President of ESWI, which works to promote understanding of influenza as a disease, and to increas the use of vaccines and antiviral drugs in order to lessen the impact of flu in Europe.</gtr:impact><gtr:outcomeId>cRW82AJJvHv</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BSI President</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3B81F4B2-01F8-49B9-8DC1-7B721DA085EB</gtr:id><gtr:impact>The British Society for Immunology (BSI) is the largest immunology society in Europe and the second largest in the world. We are a learned society representing the interests of members working in academia, clinical medicine, and industry. Our main objective is to promote and support excellence in research, scholarship and clinical practice in immunology for the benefit of human and animal health.</gtr:impact><gtr:outcomeId>H13R9hoC3Xm</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>https://immunology.org/resources-careers--education/policy-and-public-affairs/--bsi-resources-policy-and-public-affairs-</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Invitation to participate in International Influenza Networks Meeting</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0B4246C5-1420-42DC-A0E4-51A1603C38F7</gtr:id><gtr:outcomeId>UuvCuSMLoUx</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Joint Committee on Vaccination and Immunisation (influenza/RSV)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>21E46AA2-19AF-4A4A-8F03-5A2A9B82EF19</gtr:id><gtr:outcomeId>maqNs7RTDx2</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ISARIC</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D8CFB6A9-F0BB-4416-B2C5-12496C12EC26</gtr:id><gtr:impact>Large consortium of consortia, co-ordinating pandemic research internationally.</gtr:impact><gtr:outcomeId>o7Resxb2E4B</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Scientific Advisory Group in Emergencies</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>569F3732-55F1-4216-90DF-785312BC45FF</gtr:id><gtr:impact>Part of small advisory group, chaired by the Government Chief Scientist, advising the Cabinet on pandemic responses. This committee took a central role in steering the pandemic response.</gtr:impact><gtr:outcomeId>VyzwA4AXu3U</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>The adsorbative strips are placed in the nose or lung to obtain fluid samples for prognostic and diagnostic use. These were developed by Dr Hansel (a MOSAIC investigator) and have been tested experimentally in asthma and hay fever, but not on the scale used in MOSAIC.</gtr:description><gtr:id>55F337E8-BEDC-4D49-87F2-D63C3D1723E3</gtr:id><gtr:impact>The novel sampling method is expected to have clinical impact once the experimental phase is completed.</gtr:impact><gtr:outcomeId>i26CEnxT84D</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Synthetic adsorbative matrix (SAM) strips</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>The data team within MOSAIC has produced a database linking all the outputs from MOSAIC in searchable form. This unique resource contains all data collected or generated in MOSAIC. Additionally, it contains detailed documentation about what is located within the databases, methods for generating the information and other methodological details.
These data were centrally managed in our core data team, headed by a researcher with over 10 years' experience collecting, managing and analysing clinical information. All data were validated and where appropriate double entered/double checked for accuracy. Documentation and clinical decisions regarding how patients should be classified were organised by the data team through documented expert meetings and assessment of the data. These data are shared across the MOSAIC investigator teams and with other researchers through a data request scheme. Once checked and mined by MOSAIC investigators, these data will be available to any researcher on request.</gtr:description><gtr:id>D7F9DF83-6F1F-4E40-AF26-E45BD1D3E923</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>545cf5b714de19.52902008</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dataset</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The Influenza Clinical Information Network (FLU-CIN) surveillance network was established by the Department of Health in England on 11 May 2009. We have used the FLUCIN data collection form as the principal method of collecting clinical data from the study recruits</gtr:description><gtr:id>F922E674-B213-4632-93DA-294FE7659A8A</gtr:id><gtr:impact>Using this tool has enabled us to build a rich clinical dataset to complement the laboratory gerenated data from the biological samples that the study recruits provided. We have implemented rigourous validation and quality control procedures to ensure that this information is correct and in a format that will be flexible and easy to use in analysis</gtr:impact><gtr:outcomeId>BAKC3Xp58qJ</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>FLU-CIN</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The team within MOSAIC has produced a database linking all the outputs from MOSAIC in searchable form. This unique resource contains all data collected or generated in MOSAIC. Additionally, it contains detailed documentation about what is located within the databases, methods for generating the information and other methodological details.</gtr:description><gtr:id>EB85750F-296C-4D64-B110-3B33EF2085C3</gtr:id><gtr:impact>No impacts yet</gtr:impact><gtr:outcomeId>545cb3075035e5.21635890</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dataset</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have 8000 samples archived. Processing almost complete</gtr:description><gtr:id>2ECA0AA6-1603-4E54-A6DE-B9FA2146C6DC</gtr:id><gtr:impact>Laboratory analysis across the consortium is approaching conclusion having encompassed multiple disciplines. These inlcude host factors (cellular immunology, soluble mediator responses, transcriptomics and genomics), pathogen variations (influenza virus genetic and antigenic characteristics, viral shedding and viral load) and co pathogens (co-infecting or secondarily-infecting bacteria and viruses.</gtr:impact><gtr:outcomeId>E9TpLSXNbVf</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Diverse timed samples collected from cases of influenza-like illness</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have an extensive database of clinical information from 256 cases of influenza-like illness, mostly from pH1N1 influenza but also from control groups.</gtr:description><gtr:id>44D26CC7-AA82-4362-904D-F788C2259920</gtr:id><gtr:impact>Extensive material that can be cross-correlated with laboratory outputs</gtr:impact><gtr:outcomeId>reDLir874hK</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Clinical information</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>21849450-6544-43BE-BE71-9574E9654008</gtr:id><gtr:title>Doctors accepting flu vaccination is the sensible and responsible choice.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3001ef648587e32ff894d3c73f9321ca"><gtr:id>3001ef648587e32ff894d3c73f9321ca</gtr:id><gtr:otherNames>Dunning J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_15334_24_22077079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>187B6E54-8A6C-4DA2-9A13-13E2E173D1B8</gtr:id><gtr:title>Vaccination policies in Europe: Common goals, diverse approaches and public doubts.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19a3b8d10802aaf24c2c513357259cbb"><gtr:id>19a3b8d10802aaf24c2c513357259cbb</gtr:id><gtr:otherNames>Petrarca L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5a6f089d8027b1.80472521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18251589-ADBC-47B7-8EC4-A788069FD2A4</gtr:id><gtr:title>Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c77e0fe3343f631d65c2e751f3d425f"><gtr:id>8c77e0fe3343f631d65c2e751f3d425f</gtr:id><gtr:otherNames>Li GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56bb6068ee0dd9.03631115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC9AD179-6F00-4B7A-9FA3-94E39DA59244</gtr:id><gtr:title>CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe12a1cd456146721212c38919a15948"><gtr:id>fe12a1cd456146721212c38919a15948</gtr:id><gtr:otherNames>Lee DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15334_24_20573822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8189B0D-7C41-4AFE-BDE0-4F7FE964E495</gtr:id><gtr:title>Current concepts and progress in RSV vaccine development.</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abb8774495984c453ea56b2de167adf1"><gtr:id>abb8774495984c453ea56b2de167adf1</gtr:id><gtr:otherNames>Guvenel AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn><gtr:outcomeId>56bb6068359582.86979028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3FA35EC-44F2-4CC3-8125-3C1D98C654A3</gtr:id><gtr:title>Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/687a740ab5516b5ca81871697fecaffe"><gtr:id>687a740ab5516b5ca81871697fecaffe</gtr:id><gtr:otherNames>Myles PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15334_24_22407890</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90222898-17F7-4E78-8F36-D1F09BB7CF77</gtr:id><gtr:title>Crossing barriers: infections of the lung and the gut.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1eb793e41c94bae8f9d96b02241b8ad"><gtr:id>e1eb793e41c94bae8f9d96b02241b8ad</gtr:id><gtr:otherNames>Openshaw PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>pm_15334_14_19129753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C63A9A74-A7F1-4F51-9D9B-9459E676E379</gtr:id><gtr:title>Maternal immunisation: collaborating with mother nature.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23d2c8168942b16866f1d5c1e817c38e"><gtr:id>23d2c8168942b16866f1d5c1e817c38e</gtr:id><gtr:otherNames>Marchant A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5a578cf96189c1.30074720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AED074B8-4D76-4113-9234-5802E3C665B1</gtr:id><gtr:title>Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d33e4a974986fa108c568c932242ab8"><gtr:id>7d33e4a974986fa108c568c932242ab8</gtr:id><gtr:otherNames>Enstone JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>pm_15334_24_21470446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1310779D-5359-403A-BD8B-48DE53368EB3</gtr:id><gtr:title>Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05cc63115d1ca013df093252c62448ab"><gtr:id>05cc63115d1ca013df093252c62448ab</gtr:id><gtr:otherNames>Habibi MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56bb6067250938.33042341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DFDC005-634F-4C56-8F89-E6114A6180E9</gtr:id><gtr:title>Predominance of heterosubtypic IFN-?-only-secreting effector memory T cells in pandemic H1N1 naive adults.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a36a27fdba02f67bc73d13ae40289f36"><gtr:id>a36a27fdba02f67bc73d13ae40289f36</gtr:id><gtr:otherNames>Sridhar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_15334_24_22777887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF228209-B724-4A47-93F0-FFD30EF05D02</gtr:id><gtr:title>An evaluation of community assessment tools (CATs) in predicting use of clinical interventions and severe outcomes during the A(H1N1)pdm09 pandemic.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfedcdce8c925af5ebda69364250f13b"><gtr:id>cfedcdce8c925af5ebda69364250f13b</gtr:id><gtr:otherNames>Semple MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545c9ebca9dbe7.58820010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80BDC3AD-0C06-4982-A6D7-B540B34B4295</gtr:id><gtr:title>Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a136073afc0b43d7b5fc2e1d0be61ec"><gtr:id>2a136073afc0b43d7b5fc2e1d0be61ec</gtr:id><gtr:otherNames>Ellebedy AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56bb6067a4b318.73168243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A7B35A9-7156-40BD-815F-75AF3F027494</gtr:id><gtr:title>Cross-reactive humoral responses to influenza and their implications for a universal vaccine.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0ab83ce5a962ead03102dd5b014052"><gtr:id>5b0ab83ce5a962ead03102dd5b014052</gtr:id><gtr:otherNames>Chiu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>56bb6068be4ed2.39634195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05E25F29-436F-4A67-96ED-2734B50D35EC</gtr:id><gtr:title>Emerging drugs for respiratory syncytial virus infection.</gtr:title><gtr:parentPublicationTitle>Expert opinion on emerging drugs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3866b5db63c5329d6e033993c76dcf1e"><gtr:id>3866b5db63c5329d6e033993c76dcf1e</gtr:id><gtr:otherNames>Olszewska W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1472-8214</gtr:issn><gtr:outcomeId>pm_15334_14_19453286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B8114D0-5B46-4CD4-B232-90AA83FFD35F</gtr:id><gtr:title>Impact of the 2009 influenza pandemic.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3001ef648587e32ff894d3c73f9321ca"><gtr:id>3001ef648587e32ff894d3c73f9321ca</gtr:id><gtr:otherNames>Dunning J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_15334_24_20522840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C475F289-914A-4906-BD2D-94C28CE98F36</gtr:id><gtr:title>Issues in vaccinology: Present challenges and future directions.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eef2d6125fc7d7bc2d45e7213cff7610"><gtr:id>eef2d6125fc7d7bc2d45e7213cff7610</gtr:id><gtr:otherNames>Sheerin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5a6b1c2f69f2f8.65607424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35CA93D7-0790-46F3-877A-780248BEF326</gtr:id><gtr:title>Open source clinical science for emerging infections.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b471cee6b027dc7e4b623d0e604811e"><gtr:id>8b471cee6b027dc7e4b623d0e604811e</gtr:id><gtr:otherNames>Dunning JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>545a4e1ef07fa5.53656646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>461214ED-4A51-4E8E-86A0-6C947930D90E</gtr:id><gtr:title>The microbiology of asthma.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8603744bac0fd9c512c0c37ca4382a6a"><gtr:id>8603744bac0fd9c512c0c37ca4382a6a</gtr:id><gtr:otherNames>Edwards MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>pm_15334_24_22669219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96BF1F85-071B-49D7-9D62-4EFB1E94B2F2</gtr:id><gtr:title>Microbes and mucosal immune responses in asthma.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/669dfd6571c109d3af73fc733197c4e1"><gtr:id>669dfd6571c109d3af73fc733197c4e1</gtr:id><gtr:otherNames>Hansel TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>545a4e1f6e6c45.87668539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFF45D1D-73F3-4700-AD55-9179561CF7CD</gtr:id><gtr:title>Antivirals for influenza: where now for clinical practice and pandemic preparedness?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b193de6897fa9f0f5f4431dac8630231"><gtr:id>b193de6897fa9f0f5f4431dac8630231</gtr:id><gtr:otherNames>Nguyen-Van-Tam JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>545a4e1f252f27.17422644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F03923F9-66B6-447D-9ED3-96AFC37B6CF0</gtr:id><gtr:title>Antiviral B cell and T cell immunity in the lungs.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0ab83ce5a962ead03102dd5b014052"><gtr:id>5b0ab83ce5a962ead03102dd5b014052</gtr:id><gtr:otherNames>Chiu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>56bb606756a2c6.67975982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>870E90AC-138B-4770-83B9-CA58B413ED42</gtr:id><gtr:title>Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db9a89e402a484ffe65964fd920c99fb"><gtr:id>db9a89e402a484ffe65964fd920c99fb</gtr:id><gtr:otherNames>Elderfield RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545a4e1f48d039.88548458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEA9C802-2310-43B2-BEFC-BA4982D13E1D</gtr:id><gtr:title>Differences between asthmatics and nonasthmatics hospitalised with influenza A infection.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b9077f5dd8402aa1a115f8b9a5b11a3"><gtr:id>1b9077f5dd8402aa1a115f8b9a5b11a3</gtr:id><gtr:otherNames>Myles P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>pm_15334_24_22903963</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5019DCB-25BE-4505-84DE-65539B54711A</gtr:id><gtr:title>Contribution of cytokines to pathology and protection in virus infection.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/863ba9a68a78985690bfadc5f104bf49"><gtr:id>863ba9a68a78985690bfadc5f104bf49</gtr:id><gtr:otherNames>Wack A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn><gtr:outcomeId>pm_15334_24_22440716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>811527A1-0A8F-40BB-B6C5-81BE681888BC</gtr:id><gtr:title>M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f02aa2ebb10d042b908ae932541a85e1"><gtr:id>f02aa2ebb10d042b908ae932541a85e1</gtr:id><gtr:otherNames>Cole SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>5a578c31b42918.94303695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F459546-4279-48D3-8485-D76899D2539D</gtr:id><gtr:title>IFITM3 restricts the morbidity and mortality associated with influenza.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8080feaaa6a1c8bc11a2811ee3812b4f"><gtr:id>8080feaaa6a1c8bc11a2811ee3812b4f</gtr:id><gtr:otherNames>Everitt AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15334_24_22446628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED9F5F8B-7A74-4889-B3D3-055EBE0B3BC4</gtr:id><gtr:title>Vaccines in the Prevention of Viral Pneumonia.</gtr:title><gtr:parentPublicationTitle>Clinics in chest medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d04cfae86dbf76ca65a38e48c692dd0"><gtr:id>8d04cfae86dbf76ca65a38e48c692dd0</gtr:id><gtr:otherNames>Fraser CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0272-5231</gtr:issn><gtr:outcomeId>58c699d820cf10.35258397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E168965-45EC-4D54-9884-368626D9AD30</gtr:id><gtr:title>Influenza vaccination: lessons learned from the pandemic (H1N1) 2009 influenza outbreak.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1eb793e41c94bae8f9d96b02241b8ad"><gtr:id>e1eb793e41c94bae8f9d96b02241b8ad</gtr:id><gtr:otherNames>Openshaw PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>pm_15334_24_20555316</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_G1001212</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>